T1	Participants 390 523	Patients with surgically resected locally advanced (T3-4 or N1-2) or metastatic RCC were randomly assigned to 1 of 4 treatment groups
T2	Participants 1030 1040	2 patients
T3	Participants 1081 1099	Forty-one patients
T4	Participants 1130 1132	40
T5	Participants 1233 1241	patients
T6	Participants 1334 1344	8 patients
T7	Participants 1473 1484	39 patients
T8	Participants 1509 1511	31
T9	Participants 2136 2144	patients
